Emmanuel Katsanis

  • 3463 Citations
  • 33 h-Index
1986 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Neoplasms Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Immunity Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Tumors Chemical Compounds
Immunotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2003 2015

(CRCL) vaccine for Chronic Myelogenous Leukemia

Katsanis, E.

National Institutes of Health

3/1/044/30/15

Project: Research projectResearch Project

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Immunotherapy
Leukemia
Vaccines

Chaperone rich cell lysates (CRCL)Natural adjuvants and*

Katsanis, E.

National Institutes of Health

7/1/036/30/06

Project: Research projectExploratory/Developmental Grants

Dendritic Cells
Ovarian Neoplasms
Heat-Shock Proteins
Ascites
Cytotoxic T-Lymphocytes

Research Output 1986 2018

  • 3463 Citations
  • 33 h-Index
  • 100 Article
  • 2 Chapter
  • 1 Letter
Hematologic Neoplasms
Bone Marrow Transplantation
Cyclophosphamide
Young Adult
Pediatrics

Successful resolution of hyperammonemia following hematopoietic cell transplantation with directed treatment of Ureaplasma parvum infection

Graetz, R., Meyer, R., Shehab, K. & Katsanis, E., Jan 1 2018, (Accepted/In press) In : Transplant Infectious Disease.

Research output: Contribution to journalArticle

Ureaplasma Infections
Ureaplasma
Hyperammonemia
Cell Transplantation
Brain Diseases

β2-Adrenergic receptor signaling mediates the preferential mobilization of differentiated subsets of CD8+ T-cells, NK-cells and non-classical monocytes in response to acute exercise in humans

Graff, R. M., Kunz, H. E., Agha, N. H., Baker, F. L., Laughlin, M., Bigley, A. B., Markofski, M. M., LaVoy, E. C., Katsanis, E., Bond, R. A., Bollard, C. M. & Simpson, R. J., Jan 1 2018, (Accepted/In press) In : Brain, Behavior, and Immunity.

Research output: Contribution to journalArticle

T-Lymphocyte Subsets
Nadolol
Natural Killer Cells
Adrenergic Receptors
Monocytes
3 Citations

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: A CIBMTR analysis

Kanate, A. S., Digilio, A., Ahn, K. W., Al Malki, M., Jacobsen, E., Steinberg, A., Hamerschlak, N., Kharfan-Dabaja, M., Salit, R., Ball, E., Bashir, Q., Cashen, A., Couriel, D., Diez-Martin, J., Katsanis, E., Linhares, Y., Mori, S., Nash, R., Pawarode, A., Perales, M. A. & 11 othersPhipps, C. D., Richman, C., Savani, B. N., Shapira, M. Y., Stiff, P., Strair, R., Fenske, T. S., Smith, S. M., Sureda, A., Olteanu, H. & Hamadani, M., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Extranodal NK-T-Cell Lymphoma
Natural Killer T-Cells
T-Cell Lymphoma
Cell Transplantation
Nose

Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantation

Zeng, Y. . & Katsanis, E., Dec 1 2017, In : Bone Marrow Transplantation. 52, 12, p. 1671-1673 3 p.

Research output: Contribution to journalLetter

Cell Transplantation
blinatumomab